Bebanco, Recel .
HRN: 22-48-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2025
CEFUROXIME 1.5GM (VIAL)
10/10/2025
10/11/2025
IVT
1.5gm
Q 8 HRS
LTCS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes